Search Results 261-270 of 8007 for SC
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC-007 ...
... SC, Neben-Wittich MA, Ma DJ, Price KA, Lowe VJ, Van Abel KM. Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography Uptake ...
Furthermore, to characterize the DONQ52 PK profile following single and multiple subcutaneous (SC) dose(s) in celiac disease patients and to investigate the ...
She completed her residency at the University of South Carolina and her breast surgery fellowship at the University of Texas, M.D. Anderson Cancer Center. In ...
About this study. The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits ...
Coronavirus disease 2019 (COVID-19) is an illness caused by the virus SARS-CoV-2. Learn more about the symptoms, risks and ways to protect yourself.
... South CarolinaAlpha Epsilon Delta Premedical Honor Society. 2004. President's ListUniversity of South Carolina. 2004. Pi Mu Epsilon Mathematics Honor Society ...
At least one 4-week induction regimen of adalimumab (one 160 mg subcutaneous [SC] dose at Baseline, followed by one 80 mg SC dose at Week 2 [or one 80 mg SC ...
After completing residency in 2017, I joined Dermatology Associates of Greenville, SC. I currently work alongside six other excellent dermatologists. My ...
... SC, Paulson L, Clark-Swanson K, Lassiter-Morris Y, Smith KA, Nakaji P, Bendok BR, Zimmerman RS, Krishna C, Patra DP, Patel NP, Lyons M, Neal M, Donev K ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.